Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Protein Eng Des Sel ; 28(2): 45-52, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25614525

RESUMEN

Macrocyclic peptides are potentially a source of powerful drugs, but their de novo discovery remains challenging. Here we describe the discovery of a high-affinity (Kd = 10 nM) peptide macrocycle (M21) against human tumor necrosis factor-alpha (hTNFα), a key drug target in the treatment of inflammatory disorders, directly from diverse semi-synthetic phage peptide repertoires. The bicyclic peptide M21 (ACPPCLWQVLC) comprises two loops covalently anchored to a 2,4,6-trimethyl-mesitylene core and upon binding induces disassembly of the trimeric TNFα cytokine into dimers and monomers. A 2.9 Å crystal structure of the M21/hTNFα complex reveals the peptide bound to a hTNFα dimer at a normally buried epitope in the trimer interface overlapping the binding site of a previously discovered small molecule ligand (SPD304), which also induces TNF trimer dissociation and synergizes with M21 in the inhibition of TNFα cytotoxicity. The discovery of M21 underlines the potential of semi-synthetic bicyclic peptides as ligands for the discovery of cryptic epitopes, some of which are poorly accessible to antibodies.


Asunto(s)
Epítopos , Péptidos Cíclicos , Factor de Necrosis Tumoral alfa , Línea Celular , Cristalografía por Rayos X , Epítopos/química , Epítopos/metabolismo , Humanos , Péptidos Cíclicos/química , Péptidos Cíclicos/farmacología , Estructura Secundaria de Proteína , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/química , Factor de Necrosis Tumoral alfa/metabolismo
2.
J Biotechnol ; 139(4): 314-7, 2009 Feb 23.
Artículo en Inglés | MEDLINE | ID: mdl-19297727

RESUMEN

The release of volatile ethylene and acetaldehyde characterizes the metabolic state and quality of fruit. We have designed and implemented a hybrid dual-channel catalytic-biological sensor system, which is able to quantify both volatiles in situ. This sensor system consists of a mammalian cell line engineered for constitutive expression of an Aspergillus nidulans-derived biosensor which triggers quantitative reporter gene expression in the presence of volatile acetaldehyde. Ethylene, oxidized to acetaldehyde using a Wacker-based process, can be quantified by the same transgenic sensor cell line. Differential profiling of reporter gene transcription by the sensor system revealed the relative concentrations of both volatile metabolites and enabled correct assessment of fruit quality as shown for fresh, old and rotten apples. Functional combination of catalytic processes with biosensor technology is able to precisely capture the metabolic state of food and may foster novel insight into biochemical food quality assessment as well as the design of synthetic control circuits detecting and preventing food spoilage.


Asunto(s)
Técnicas Biosensibles/métodos , Análisis de los Alimentos/métodos , Frutas/química , Malus/química , Acetaldehído/análisis , Aspergillus nidulans/genética , Proteínas de Unión al ADN/metabolismo , Etilenos/análisis , Proteínas Fúngicas/metabolismo
3.
Nucleic Acids Res ; 37(4): e33, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19190091

RESUMEN

Electric signal processing has evolved to manage rapid information transfer in neuronal networks and muscular contraction in multicellular organisms and controls the most sophisticated man-built devices. Using a synthetic biology approach to assemble electronic parts with genetic control units engineered into mammalian cells, we designed an electric power-adjustable transcription control circuit able to integrate the intensity of a direct current over time, to translate the amplitude or frequency of an alternating current into an adjustable genetic readout or to modulate the beating frequency of primary heart cells. Successful miniaturization of the electro-genetic devices may pave the way for the design of novel hybrid electro-genetic implants assembled from electronic and genetic parts.


Asunto(s)
Electricidad , Regulación de la Expresión Génica , Ingeniería Genética/métodos , Transcripción Genética , Animales , Células CHO , Cricetinae , Cricetulus , Microelectrodos , Miniaturización , Miocitos Cardíacos/metabolismo , Ratas , Transgenes
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA